CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AGY.L

10µg of R21 with 50µg Matrix-M1

Phase 2
Allergy Therapeutics plc (AGY.L)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Prevention of Malaria Transmission and Clinical Malaria

View Full Landscape
Drug Information

Target Indication

Prevention of Malaria Transmission and Clinical Malaria

Clinical Trial

NCT07147400

Last updated: 9/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.